澳大利亚华商：一直视中国为亚太地区重要战略市场

Core Viewpoint - Homart Group views China as a key strategic market in the Asia-Pacific region and is increasing its investment in the Chinese market [1][2] Group 1: Company Overview - Homart Group, established in 1992, focuses on the health and nutrition sector and has multiple cGMP-certified production bases in Australia and New Zealand [2] - The company has obtained various international certifications, including TGA, FDA, halal, and organic production [2] - Homart is preparing for a listing on the Australian Securities Exchange to seek broader international cooperation opportunities [2] Group 2: Market Engagement - Homart participated in the 15th China International Health Products Expo, showcasing Australia's latest achievements in health products and promoting deeper cooperation between China and Australia [1] - The expo is a significant platform for the health and nutrition industry in the Asia-Pacific region, attracting global enterprises and professionals [1] - During the expo, Homart engaged in brand exchange sessions and trade matching activities, discussing product compliance, channel cooperation, and market trends with Chinese enterprises and institutions [2] Group 3: Market Trends - The demand for high-quality nutrition and health products in China is continuously growing as the country accelerates its health initiatives [2] - Australia is recognized as a major exporter of health products, possessing advantages in quality regulation and product development [2] - The potential for cooperation between China and Australia in the health sector is increasingly being realized [2]